Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute on Drug Abuse (NIDA) aims to create a specialized entrepreneurship teaching program centered on substance use disorder (SUD) that equips domestic researchers with the skills to translate scientific discoveries into viable biomedical products. This program will deliver a customized curriculum focused on early-stage innovation in drug addiction research, covering critical aspects such as business ideation, market evaluation, customer discovery, intellectual property protection, regulatory considerations, reimbursement processes, and capital sourcing including SBIR/STTR funding. The goal is to prepare academic researchers to effectively commercialize their work and facilitate real-world impact on populations affected by SUD. While applications are not currently being accepted, this notice serves to inform potential applicants so they can prepare a grant proposal that includes a hybrid curriculum with both in-person and online components, as well as an outreach plan to recruit U.S.-based SUD innovators and researchers. This initiative is authorized under specific U.S. Code sections and will be managed by the National Institutes of Health within the Department of Health and Human Services. Contact for further information is provided for project planning and grant preparation.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute on Drug Abuse (NIDA) seeks to advance its mission by establishing a well-recognized entrepreneurship teaching program with the demonstrated ability and passion to adapt, develop, and deliver a customized, substance use disorder (SUD)-centric curriculum in entrepreneurship and biomedical product development, targeting domestic innovators in the field of SUD research. With the appropriate training and guidance for the drug addiction science workforce, academic researchers will be better equipped with the skills to translate their discoveries into products, thus facilitating groundbreaking solutions generated in academic research to reach the populations they intend to help. The course will focus on early-stage innovation endeavors in preparing drug addiction researchers to recognize the potential of their research ideas and critically assess them for viable product development opportunities; utilize business ideation tools to evaluate the market and understand paths to commercialization; perform customer discovery; establish intellectual property protections; develop approaches to regulatory considerations; understand the reimbursement landscape; source capital, such as Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding; and generate revenue.
Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop a grant application to include both a proposed curriculum to be delivered in a hybrid format, in which a portion of the course must be offered for in-person attendance, and outreach strategy outlining the plans to recruit US-based SUD researchers and innovators to take part in the course. Grant authorities that allow NIDA to forecast this opportunity are as follows: Section 301 (42 U.S.C. § 241) and Section 405 (42 U.S.C. § 284).